Felix J. Kim

849 total citations
18 papers, 681 citations indexed

About

Felix J. Kim is a scholar working on Molecular Biology, Immunology and Ecology, Evolution, Behavior and Systematics. According to data from OpenAlex, Felix J. Kim has authored 18 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Ecology, Evolution, Behavior and Systematics. Recurrent topics in Felix J. Kim's work include Pharmacological Receptor Mechanisms and Effects (12 papers), Receptor Mechanisms and Signaling (8 papers) and T-cell and Retrovirus Studies (5 papers). Felix J. Kim is often cited by papers focused on Pharmacological Receptor Mechanisms and Effects (12 papers), Receptor Mechanisms and Signaling (8 papers) and T-cell and Retrovirus Studies (5 papers). Felix J. Kim collaborates with scholars based in United States, France and Argentina. Felix J. Kim's co-authors include Christina M. Maher, Marc Sitbon, Gavril W. Pasternak, Jean‐Luc Battini, Nicolas Manel, Jeffrey D. Thomas, Chih‐Cheng Chien, Ivanka Kovalyshyn, Brett A. Neilan and Jane Y. Tong and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Journal of Virology.

In The Last Decade

Felix J. Kim

18 papers receiving 674 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Felix J. Kim United States	12	436	180	145	91	68	18	681
Alan Harris Tanzania	11	326 0.7×	113 0.6×	34 0.2×	41 0.5×	11 0.2×	12	544
Weixing Yang United States	7	162 0.4×	64 0.4×	60 0.4×	40 0.4×	18 0.3×	8	420
Nishi Sharma United States	15	359 0.8×	143 0.8×	72 0.5×	49 0.5×	10 0.1×	24	702
Wolfram Lehmann Germany	11	425 1.0×	37 0.2×	108 0.7×	115 1.3×	18 0.3×	52	673
Chiara D’Onofrio Italy	11	162 0.4×	133 0.7×	15 0.1×	27 0.3×	79 1.2×	41	349
Sulabha Argade United States	12	384 0.9×	53 0.3×	31 0.2×	28 0.3×	5 0.1×	18	624
Ingeburg E. Goetz United States	13	246 0.6×	45 0.3×	77 0.5×	52 0.6×	12 0.2×	19	473
Sharon Karniely Israel	14	620 1.4×	41 0.2×	27 0.2×	39 0.4×	36 0.5×	21	796
C S Flordellis United States	11	293 0.7×	48 0.3×	92 0.6×	41 0.5×	7 0.1×	15	445
Dietrich Simon Germany	16	681 1.6×	98 0.5×	14 0.1×	58 0.6×	23 0.3×	27	871

Countries citing papers authored by Felix J. Kim

Since Specialization

Citations

This map shows the geographic impact of Felix J. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felix J. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felix J. Kim more than expected).

Fields of papers citing papers by Felix J. Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Felix J. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felix J. Kim. The network helps show where Felix J. Kim may publish in the future.

Co-authorship network of co-authors of Felix J. Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Felix J. Kim. A scholar is included among the top collaborators of Felix J. Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felix J. Kim. Felix J. Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Kim, Felix J., et al.. (2020). Small‐Molecule Sigma1 Modulator Suppresses PD‐L1‐Mediated Cancer Cell Adaptive Immune Resistance in Response to Interferon‐Gamma. The FASEB Journal. 34(S1). 1–1. 1 indexed citations

Sanders, Christina M., et al.. (2019). Small-Molecule Modulators of Sigma1 and Sigma2/TMEM97 in the Context of Cancer: Foundational Concepts and Emerging Themes. Frontiers in Pharmacology. 10. 1141–1141. 45 indexed citations

Kim, Felix J. & Gavril W. Pasternak. (2018). σ1 Receptor ligand binding: an open-and-shut case. Nature Structural & Molecular Biology. 25(11). 992–993. 6 indexed citations

Thomas, Jeffrey D., Nan Chen, Christina M. Maher, et al.. (2017). Sigma1 Targeting to Suppress Aberrant Androgen Receptor Signaling in Prostate Cancer. Cancer Research. 77(9). 2439–2452. 37 indexed citations

Maher, Christina M., et al.. (2017). Small-Molecule Sigma1 Modulator Induces Autophagic Degradation of PD-L1. Molecular Cancer Research. 16(2). 243–255. 129 indexed citations

Kim, Felix J. & Christina M. Maher. (2017). Sigma1 Pharmacology in the Context of Cancer. Handbook of experimental pharmacology. 244. 237–308. 62 indexed citations

Salvino, Joseph M., et al.. (2017). Novel small molecule guanidine Sigma1 inhibitors for advanced prostate cancer. Bioorganic & Medicinal Chemistry Letters. 27(10). 2216–2220. 4 indexed citations

Kim, Felix J.. (2017). Introduction to Sigma Proteins: Evolution of the Concept of Sigma Receptors. Handbook of experimental pharmacology. 244. 1–11. 17 indexed citations

Kim, Felix J. & Gavril W. Pasternak. (2017). Sigma Proteins: Evolution of the Concept of Sigma Receptors. Handbook of experimental pharmacology. 3 indexed citations

10.

Stabler, Stacy M., et al.. (2013). Sequential Cytoprotective Responses to Sigma1 Ligand–Induced Endoplasmic Reticulum Stress. Molecular Pharmacology. 84(5). 751–762. 46 indexed citations

11.

Kim, Felix J., et al.. (2012). Inhibition of tumor cell growth by Sigma1 ligand mediated translational repression. Biochemical and Biophysical Research Communications. 426(2). 177–182. 24 indexed citations

12.

Kim, Felix J., et al.. (2010). σ1 Receptor Modulation of G-Protein-Coupled Receptor Signaling: Potentiation of Opioid Transduction Independent from Receptor Binding. Molecular Pharmacology. 77(4). 695–703. 122 indexed citations

13.

Kim, Felix J., Antoine Gessain, Sandra Gallego, et al.. (2006). Intrahost variations in the envelope receptor-binding domain (RBD) of HTLV-1 and STLV-1 primary isolates. Retrovirology. 3(1). 29–29. 5 indexed citations

14.

Kim, Felix J., Nicolas Manel, Jean‐Luc Battini, & Marc Sitbon. (2004). La capture d’enveloppe par les rétrovirus. médecine/sciences. 20(10). 876–881. 3 indexed citations

15.

Kim, Felix J., et al.. (2004). HTLV-1 and -2 envelope SU subdomains and critical determinants in receptor binding. Retrovirology. 1(1). 41–41. 47 indexed citations

16.

Kim, Felix J., Jean‐Luc Battini, Nicolas Manel, & Marc Sitbon. (2003). Emergence of vertebrate retroviruses and envelope capture. Virology. 318(1). 183–191. 54 indexed citations

17.

Kim, Felix J., Nicolas Manel, Yvan Boublik, Jean‐Luc Battini, & Marc Sitbon. (2002). Human T-Cell Leukemia Virus Type 1 Envelope-Mediated Syncytium Formation Can Be Activated in Resistant Mammalian Cell Lines by a Carboxy-Terminal Truncation of the Envelope Cytoplasmic Domain. Journal of Virology. 77(2). 963–969. 38 indexed citations

18.

Kim, Felix J., Iban Seiliez, Caroline Denesvre, et al.. (2000). Definition of an Amino-terminal Domain of the Human T-cell Leukemia Virus Type 1 Envelope Surface Unit That Extends the Fusogenic Range of an Ecotropic Murine Leukemia Virus. Journal of Biological Chemistry. 275(31). 23417–23420. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact